Table 2.
Age/Sex | Comorbidity | Co-Detections | ICU Admission | Radiology | SOFA/APACHE/SAPS II | Duration ICU Stay | Summary |
---|---|---|---|---|---|---|---|
62/M | Heroin abuse | Stenotrophomonas maltophilia (sputum culture) | Hypoxia | Bilateral consolidation, multilobar infiltrates, pleural effusion | 4/82/29 | 14 days | IMV: yes, duration 13 days Proning: yes |
66/M | nsclc in active treatment | Rhinovirus (PCR) Streptococcus pneumonia (sputum culture) |
Hemodynamic instability with new onset SVT | Interlobar septa thickening, pleural effusion, ground glass opacities | 2/52/24 | 1 day | IMV: no NIMV: no Hemodynamic instability (new onset arrhythmia) |
72/M | Diabetes mellitus type 2, smoking | None | Hypoxia | Bilateral consolidations | 4/59/36 | 4 days | IMV: no NIMV: high-flow nasal cannula ROX at admission 3.61 |
18/M | Wilms tumor at age 1 | None | Hypoxia | Ground glass, bilateral consolidations, tree in bud | 4/39/17 | 7 days | IMV: yes, duration 6 days Proning: yes (non-responder) NIMV: high-flow nasal cannula ROX at admission: 2.8 |
50/F | None | Bordetella pertussis (PCR NP/OP swab) | Hemodynamic instability with new onset SVT | Consolidation right lower lobe | 2/39/36 | 1 day | IMV: no NIMV: no Hemodynamic instability (new onset arrhythmia) |
29/M | West syndrome with tetraparesis | None | Hypoxia | Retro cardiac consolidation | 4/26/12 | 2 days | IMV: no NIMV: yes, 48 h of high-flow nasal cannula ROX at admission: 5.47 |
60/M | None | None | Hypoxia | Left peri hilar consolidation | 1/49/18 | 5 days | IMV: no NIMV: yes, 108 h of high-flow nasal cannula ROX at admission: 3.26 |
48/M | Smoking | Adenovirus (PCR NP/OP swab) | Upper airway obstruction | No pulmonary pathology; soft tissue/lymphnode swollen, no abscess, no signs of sinusitis | 5/25/22 | 3 days | IMV: yes, upper airway obstruction. Duration 48 h |
43/M | None | Rhinovirus (PCR NP/OP swab) | Hypoxia | Consolidations right lower lobe and midlle lobe and left lower lobe | 1/38/18 | 6 days | IMV: no NIMV: 5 days of high-flow nasal cannula ROX at admission: 7.46 |
77/M | Organizing pneumonia | None | Hypoxia | Right lower middle and upper lobe new consolidations, pleural effusion right | 2/79/24 | 6 days | IMV: no NIMV: 5 days of high-flow nasal cannula ROX at admission: 5.17 |
27/F | None | None | Hypoxia | Consolidation left lower lobe | 2/25/9 | 5 days | IMV: no NIMV: 4 days of high-flow nasal cannula ROX at admission: 8.61 |
26/M | None | None | Hypoxia | Reticonodular consolidations right lower lobe | 4/37/22 | 7 days | IMV: yes, duration 4 days NIMV: yes |
36/M | None | None | Hypoxia | Consolidation righ lower lobe and peribronchial cuffing | 4/41/17 | 11 days | IMV: no NIMV: high-flow nasal cannula ROX at admission: - |
44/M | Coeliac disease | None | Hypoxia | Bilateral consolidations | 3/45/20 | 19 days | IMV: yes, duration 9 days Proning: yes NIMV: yes |
36/M | None | None | Hypoxia | Reticonodular consolidations in the lower lobes | 4/46/21 | 5 days | IMV: no NIMV: high-flow nasal cannula |
29/F | Colitis Ulcerosa | None | Hypoxia | Bilateral patchy consolidations | 3/51/21 | 2 days | IMV: no NIMV: high-flow nasal cannula |
65/M | Heart failure, OSAS, chronic renal insufficiency, diabetes mellitus type 2 | SARS-CoV-2 (PCR NP/OP swab), Streptococcus pneumonia (pleural fluid and blood culture) | Hemodynamic instability | Consolidation left lower lobe with pleural effusion | 5/79/37 | 1 day | IMV: no NIMV: no |